METROPOLIS — Metropolis Healthcare Income Statement
0.000.00%
- IN₹88.05bn
- IN₹88.87bn
- IN₹13.31bn
- 97
- 10
- 36
- 46
Annual income statement for Metropolis Healthcare, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IAS | IAS | IAS | IAS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 9,980 | 12,283 | 11,482 | 12,077 | 13,312 |
Cost of Revenue | |||||
Gross Profit | 7,284 | 9,318 | 8,739 | 9,354 | 10,523 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 7,551 | 9,310 | 9,446 | 10,097 | 11,369 |
Operating Profit | 2,429 | 2,974 | 2,036 | 1,980 | 1,943 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 2,443 | 2,934 | 1,875 | 1,747 | 1,909 |
Provision for Income Taxes | |||||
Net Income After Taxes | 1,833 | 2,147 | 1,434 | 1,285 | 1,455 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 1,831 | 2,142 | 1,429 | 1,278 | 1,450 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 1,831 | 2,142 | 1,429 | 1,278 | 1,450 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 35.8 | 39.4 | 27.8 | 24.9 | 28.1 |
Dividends per Share |